Denmark· DK-28105312313
Casenlax
A macrogol product containing macrogol 4000, registered in Denmark by Casen Recordati, S.L.. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Macrogol is registered in 12 of 19 countries.
Countries holding a registration under ATC A06AD15 (macrogol), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Macrogol · ATC A06AD15
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
Price per daily dose
What a daily dose of macrogol costs, country by country.
Normalised to the WHO defined daily dose (10 g), the median price runs from $0.083 in Finland to $0.66 in Switzerland — a ×7.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Macrogol · price per daily dose (10 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.66
- FI Finland$0.083
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- MACROGOL 4000
- Manufacturer
- Casen Recordati, S.L.
- Country
- Denmark (DK)
- ATC code
- A06AD15
- ATC class
- Macrogol
- Defined daily dose
- 10 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105312313
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
449 interactions on record for macrogol.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Macrogol · interactions on record
449 records
- 37 severe
- 411 moderate
- 1 minor
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A06AD15
Macrogol, as other registers publish it.
- DenmarkCasenlaxCasen Recordati, S.L.
- FinlandCasenlaxCasen Recordati, S.L.
- FinlandCasenlaxCasen Recordati, S.L.
- SpainCASENLAX 10 g POLVO PARA SOLUCION ORAL EN SOBRECasen Recordati S.L.
- SpainCASENLAX 10 G SOLUCION ORAL EN SOBRECasen Recordati S.L.
- SpainCASENLAX 4 g POLVO PARA SOLUCION ORAL EN SOBRESCasen Recordati S.L.
- CanadaCLEARLAXPERRIGO INTERNATIONAL
- CanadaCOMFILAXCELLCHEM PHARMACEUTICALS INC.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4f78c45f-8048-4c64-807f-e374bc4c11e0 GET /v1/drugs/4f78c45f-8048-4c64-807f-e374bc4c11e0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til oral opløsning, breve",
"source": "dkma",
"strength": "4 g",
"auth_role": "CMS",
"dk_drugid": "28105312313",
"substance": "MACROGOL 4000",
"auth_procedure": "MRP",
"in_medicinpriser": false,
"registration_date_serial": "41689"
}See everything about macrogol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.